Enterprises seeking to make good on the promise of agentic AI will need a platform for building, wrangling, and monitoring AI agents in purposeful workflows. In this quickly evolving space, myriad ...

Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology ...

In Part 4, Carolyn Krause learns more about the processes behind BWXT and LIS Technologies, which will be part of the nuclear hub.